Cardioesophageal Cancer: Best Treatment Strategies
نویسنده
چکیده
Objective: We examined the clinicomorphologic factors associated with the lowand high-risk of generalization of cardioesophageal cancer (CEC) (T1-4N0-2M0) after complete (R0) esophagogastrectomies (EG) through left thoracoabdominal incision. Methods: We analyzed data of 175 consecutive CEC patients (CECP) (age = 55.3 ± 8.7 years; tumor size = 6.9 ± 3.3 cm) radically operated and monitored in 1975-2008 (males = 132, females = 43; combined EG with resection of pancreas, liver, diaphragm, colon transversum, lung, trachea, pericardium, splenectomy 71; lymphadenectomy D2 98, D3-D4 77; esophagogastroanastomosis 98, esophagoenteroanastomosis 77; adenocarcinoma 112, squamous cell carcinoma 58, mix 5; T1 24, T2 38, T3 66, T4 47; N0 70, N1 22, N2 83; G1 52, G2 34, G3 89; surgery alone 128; surgery and adjuvant chemoimmunotherapy-AT: 5FU + thymalin/taktivin, 5-6 cycles 47 CECP). Variables selected for 5-year survival (5YS) study were input levels of 45 blood parameters, sex, age, TNMPG, cell type, tumor size. Survival curves were estimated by the Kaplan-Meier method. Differences in curves between groups of CECP were evaluated using a log-rank test. Multivariate Cox modeling, multi-factor clustering, structural equation modeling, Monte Carlo, bootstrap simulation and neural networks computing were used to determine any significant dependence. Results: For total of 175 CECP overall life span (LS) was 1381.6 ± 1486.7 days, (median 723 days) and cumulative 5YS reached 36.1%, 10 years 26.6%. 53 CECP lived more than 5 years without CEC progressing. 104 CECP died because of CEC during the first 5 years after surgery. 5YS of CECP was superior significantly after AT (69.9%) compared with surgery alone (26.6%) (P = 0.000 by log-rank test). Cox modeling displayed that 5YS of CECP (n = 175) after complete EG significantly depended on: phase transition (PT) early-invasive CEC, PT N0-N12, AT, age, T, tumor growth, Rh-factor, blood cell subpopulations, cell ratio factors (P = 0.000-0.047). Neural networks computing, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and early-invasive CEC (rank = 1), PT N0-N12 (rank = 2), AT (rank = 3), T (4), gender (5), prothrombin index (6), weight (7), glucose (8), age (9), coagulation time (10), eosinophils/cancer cells (11), erythrocytes/cancer cells (12), hemorrhage time (13), protein (14), Hb (15), segmented neutrophils/cancer cells (16), stab neutrophils/cancer cells (17). Correct prediction of 5YS was 100% by neural networks computing (error = 0.0009e-12; urea under ROC curve = 1.0). Conclusions: Best treatment strategies for CECP are: 1) screening and early detection of CEC; 2) availability of very experienced thoracoabdominal surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate abdominal, mediastinal, cervical lymphadenectomy for completeness; 4) high-precision prediction; 5) adjuvant chemoimmunotherapy for CECP with unfavorable prognosis.
منابع مشابه
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
The success of targeted cancer therapy is limited by drug resistance that can result from tumor genetic heterogeneity. The current approach to address resistance typically involves initiating a new treatment after clinical/radiographic disease progression, ultimately resulting in futility in most patients. Towards a potential alternative solution, we developed a novel computational framework th...
متن کاملA review of the role of dopamine receptors and novel therapeutic strategies in non-small cell lung cancer (NSCLC)
Lung cancer is a very aggressive and most deadly cancer in both men and women. Lung cancer is divided into two types of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is divided into 3 subgroups: adenocarcinoma (AC), squamous cell carcinoma (SqCC) and large cell carcinoma (LCC). Dopamine is involved in controlling motions, cognition, emotions, memory and reward mech...
متن کاملImmunotherapy for Breast Cancer Treatment
Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel str...
متن کاملNanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment
Despite development of new approaches for the treatment of cancer disease, it is the second cause of mortality in world. Annually, 30000 persons die in Iran due to cancer diseases. Eighty percent of cancer patients are children which about 50% children lead to death. Given the high rate of cancer-related death, the new approaches for prevention, control, early diagnosis, and treatment of this d...
متن کاملChronic pain in the cancer survivor: a new frontier.
OBJECTIVE This monograph is intended to clarify the clinical problem of chronic pain in cancer patients. DESIGN A pertinent literature review on chronic pain syndromes in cancer patients was undertaken using Medline. Further, the treatment strategies for cancer versus chronic pain are contrasted and clarified. RESULTS With increasing cancer survivorship come new challenges in patient care. ...
متن کامل